Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Colorectal Neoplasms × Imatinib Mesylate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Leukemia 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Gastrointestinal Stromal Tumors 13 Leukemia, Myeloid, Chronic-Phase 12 Leukemia, Myeloid 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Philadelphia Chromosome 5 Blast Crisis 5 Sarcoma 4 Recurrence 4 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Bone Marrow Diseases 4 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Breast Neoplasms 3 Stomach Neoplasms 2 Polycythemia Vera 2 Neurofibromatoses 2 Neoplasms by Histologic Type 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2

Interventions

Bevacizumab 112 Fluorouracil 97 Oxaliplatin 96 Leucovorin 95 Irinotecan 85 Capecitabine 73 Cetuximab 63 Panitumumab 42 pembrolizumab 36 regorafenib 28 Nivolumab 22 IFL protocol 21 Folfox protocol 21 trifluridine tipiracil drug combination 14 Radiotherapy 13 durvalumab 11 Gemcitabine 10 Celecoxib 9 tremelimumab 7 binimetinib 7 aflibercept 7 Drug Therapy 7 Disulfides 7 Cyclophosphamide 7 Trifluridine 6 Trastuzumab 6 Sunitinib 6 Immunoglobulin G 6 Colonoscopy 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00867334 2020-06-30

NITMEC

Inova Health Care Services

Phase 1/2 Completed

10 enrolled 9 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡